Evaluation of the R-Biopharm RIDA®GENE Panton-Valentine leukocidin (PVL) kit for the detection of Staphylococcus

C Bouchiat1, M Bes, C Bouveyron

  • 1Centre National de Référence des Staphylocoques, Hospices Civils de Lyon, Lyon, France, coralie.bouchiat@chu-lyon.fr.

Insights

The RIDA®GENE PVL kit can accurately detect Panton-Valentine leukocidin (PVL) genes directly from Staphylococcus aureus pus samples. This commercial assay offers a sensitive and specific alternative for diagnosing skin and soft-tissue infections.

Area of Science:

  • Microbiology
  • Molecular Diagnostics
  • Infectious Diseases

Background:

  • Panton-Valentine leukocidin (PVL) is a toxin produced by Staphylococcus aureus strains.
  • PVL is strongly associated with severe skin and soft-tissue infections (SSTI).
  • Accurate and rapid detection of PVL-encoding genes is crucial for clinical management.

Purpose of the Study:

  • To evaluate the RIDA®GENE PVL kit for direct detection of PVL genes in pus samples.
  • To compare the performance of the commercial kit with an in-house PCR method.
  • To assess the kit's utility in diagnosing S. aureus SSTI.

Main Methods:

  • Pus samples from S. aureus SSTI were analyzed using the RIDA®GENE PVL kit directly from sterile containers or Eswabs.
  • Performance was compared against an in-house PCR assay using parallel cultures as the gold standard.
  • Specificity was tested using Streptococcus pyogenes samples and S. aureus reference strains.

Main Results:

  • The RIDA®GENE PVL kit demonstrated high sensitivity (96.4%) and 100% specificity.
  • The kit performed equally well when tested directly from sterile containers or Eswabs.
  • Sensitivity was reduced (67.9%) when using regular SSTI swabs.

Conclusions:

  • The RIDA®GENE PVL kit is an effective tool for rapid PVL gene detection in S. aureus pus samples.
  • The commercial kit offers a sensitive and specific diagnostic method for SSTI.
  • Direct detection from pus samples streamlines the diagnostic process.